Skip to content

心流公司

US · HTFL #2217 按市值排名 上市于 2025
48.29 -2.62 -5.14%
实时 - 追踪5344个代码 - 心跳于495秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

涨跌不一/平稳
  • 最近一期（2026/Q3）披露持股的机构数量增加了1家。
  • 机构持股总比例基本持平。

机构持股

机构持股比例
106.00% +0.04pp
机构数量
241 +1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund66.12%
VC/PE Fund25.21%
Hedge Fund10.15%
Individual/Insider6.60%
Public Company2.42%
Private Company0.74%
Insurance Company0.69%
Sovereign Wealth Fund0.34%
Government Pension Fund0.20%

主要股东 截至 2026-07-31

Wellington Management Group 10.62% · 9.23M 股
Bain Capital Life Sciences Investors, LLC 9.72% · 8.45M 股
KKR & Co. Inc. 6.30% · 5.47M 股
BlackRock 5.98% · 5.20M 股
FMR 5.54% · 4.82M 股
Vanguard Portfolio Management, LLC 4.12% · 3.58M 股
Lonnie Smith 4.00% · 3.47M 股
Baron Capital Group, Inc. 3.71% · 3.23M 股
USVP Management Company, LLC 3.65% · 3.17M 股
Vanguard Capital Management, LLC 3.44% · 2.99M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 14次买入 · 36次卖出

姓名职务持股比例
John Farquhar Chief Executive Officer 0.37%
William Weldon Independent Chairperson 0.28%
Timothy Barabe Independent Director 0.22%
Campbell Rogers Chief Medical Officer & Executive VP 0.19%
Vikram Verghese Chief Financial Officer 0.09%
Julie Cullivan Independent Director 0.03%
Mhairi Jones -- 0.02%
Casey Tansey Independent Director 0.02%
USVP Management Company, LLC -- --
HealthCor Management L.P. -- --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-17 Campbell Rogers Chief Medical Officer & Executive VP Automatic Disposition -6,503 $50.15
2026-09-17 Campbell Rogers Chief Medical Officer & Executive VP Derivative Exercise and Sale -13,179 $2.22–50.15
2026-09-17 Vikram Verghese Chief Financial Officer Automatic Disposition -24,345 $50.11–50.75
2026-09-17 Vikram Verghese Chief Financial Officer Intent to Sell (Form 144) -16,766 $50.75
2026-09-16 Vikram Verghese Chief Financial Officer Intent to Sell (Form 144) -7,579 $50.11
2026-09-14 Vikram Verghese Chief Financial Officer Automatic Disposition -34,975 $50.01–50.24
2026-09-14 Vikram Verghese Chief Financial Officer Intent to Sell (Form 144) -668 $50.01
2026-09-13 Vikram Verghese Chief Financial Officer Intent to Sell (Form 144) -4,593 $50.24
2026-09-10 John Farquhar Chief Executive Officer Automatic Disposition -38,900 $46.42–50.00
2026-09-10 John Farquhar Chief Executive Officer Intent to Sell (Form 144) -3,890 $50.00
2026-09-10 Vikram Verghese Chief Financial Officer Intent to Sell (Form 144) -29,714 $50.06
2026-09-09 John Farquhar Chief Executive Officer Intent to Sell (Form 144) -35,010 $46.42
2026-09-07 Vikram Verghese Chief Financial Officer Automatic Disposition -6,640 $50.03
2026-09-02 Vikram Verghese Chief Financial Officer Automatic Disposition -33,416 $49.69–50.60
2026-09-02 Vikram Verghese Chief Financial Officer Intent to Sell (Form 144) -27,540 $49.69
2026-09-01 Vikram Verghese Chief Financial Officer Intent to Sell (Form 144) -5,876 $50.60
2026-08-20 John Farquhar Chief Executive Officer Automatic Disposition -27,230 $50.00
2026-08-17 John Farquhar Chief Executive Officer Automatic Disposition -32,676 $45.00
2026-08-16 Campbell Rogers Chief Medical Officer & Executive VP Derivative Exercise and Sale -9,219 $19.00–41.23
2026-08-13 John Farquhar Chief Executive Officer Automatic Disposition -15,560 $39.06

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:26 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

心流公司 讨论区 0 条评论

发表评论